medsci-skills 4.1.0

package/skills/find-journal/references/journal_profiles/Lancet_Infectious_Diseases.md

@@ -0,0 +1,38 @@
+# The Lancet Infectious Diseases
+
+## Identity
+- **Abbreviation:** Lancet Infect Dis
+- **Publisher:** Elsevier (Lancet Group)
+- **ISSN:** 1473-3099 / 1474-4457
+- **Homepage:** https://www.thelancet.com/journals/laninf
+- **Author guidelines:** https://www.thelancet.com/laninf/information-for-authors
+
+## Scope
+The Lancet Infectious Diseases publishes high-impact original research, reviews, and commentary on all aspects of infectious diseases, including clinical, public health, and microbiological perspectives. It prioritizes studies with global health significance, large-scale trials, and translational findings relevant to infection prevention, diagnosis, and treatment.
+
+## Scope Keywords
+infectious diseases, global health, antimicrobial resistance, vaccines, HIV/AIDS, tuberculosis, malaria, emerging infections, pandemic preparedness, clinical trials, epidemiology, infection control, antimicrobial stewardship, neglected tropical diseases, outbreak response, diagnostics, public health interventions
+
+## Article Types Accepted
+- Original Research (Articles)
+- Review
+- Personal View
+- Comment
+- Correspondence
+- Series
+- Health Policy
+
+## Classification
+- **Tier:** Q1
+- **Open Access:** Hybrid (optional OA)
+- **Field:** Infectious diseases
+
+## Special Notes
+The Lancet Infectious Diseases is the leading specialty journal in ID with IF ~31. It shares the Lancet Group submission system and editorial standards; manuscripts rejected from The Lancet may be transferred. The journal strongly favors large multicenter trials, systematic reviews with global scope, and policy-relevant epidemiological studies.
+
+## AI Writing Disclosure Policy
+- **Requirement level:** Required
+- **Permitted scope:** Language editing only (not intellectual contribution)
+- **Disclosure location:** Acknowledgments
+- **AI-generated images:** Not permitted without disclosure
+- **Policy URL:** https://www.thelancet.com/laninf/information-for-authors

package/skills/find-journal/references/journal_profiles/Lancet_Neurology.md

@@ -0,0 +1,39 @@
+# Lancet Neurology
+
+## Identity
+- **Abbreviation:** Lancet Neurol
+- **Publisher:** Lancet / Elsevier
+- **ISSN:** 1474-4422 / 1474-4465
+- **Homepage:** https://www.thelancet.com/journals/laneur/home
+- **Author guidelines:** https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(00)X0015-0/fulltext
+
+## Scope
+The Lancet Neurology publishes original research, reviews, and personal views across all areas of clinical neurology and neuroscience with clinical relevance. Coverage includes stroke, dementia, epilepsy, movement disorders, multiple sclerosis, neuro-oncology, neuromuscular disease, neuroinfection, and headache. The journal prioritizes large-scale clinical trials, major epidemiological studies, and translational research that advances patient care in neurological disease.
+
+## Scope Keywords
+neurology, stroke, dementia, Alzheimer disease, epilepsy, Parkinson disease, multiple sclerosis, movement disorders, neuro-oncology, neuromuscular disease, headache, traumatic brain injury, neuroimmunology, clinical neuroscience, neurodegeneration
+
+## Article Types Accepted
+- Original Research (Articles)
+- Review
+- Series
+- Seminar
+- Personal View
+- Comment
+- Correspondence
+
+## Classification
+- **Tier:** Q1
+- **Impact Factor:** ~45
+- **Open Access:** Hybrid
+- **Field:** Neurology
+
+## Special Notes
+The Lancet Neurology is the highest-impact specialty neurology journal. It shares the Lancet Group editorial policies, formatting requirements, and submission platform. Manuscripts must have a structured Summary (Background, Methods, Findings, Interpretation, Funding). The journal is highly selective (~5% acceptance) and favors multicenter RCTs, landmark cohort studies, and comprehensive systematic reviews that shape clinical practice or guidelines.
+
+## AI Writing Disclosure Policy
+- **Requirement level:** Required
+- **Permitted scope:** AI tools may assist with writing but cannot be authors; authors retain full responsibility
+- **Disclosure location:** Acknowledgments or Methods section
+- **AI-generated images:** Must be disclosed
+- **Policy URL:** https://www.thelancet.com/pb/assets/raw/Lancet/authors/lancet-information-for-authors.pdf

package/skills/find-journal/references/journal_profiles/Lancet_Oncology.md

@@ -0,0 +1,40 @@
+# Lancet Oncology
+
+## Identity
+- **Abbreviation:** Lancet Oncol
+- **Publisher:** Lancet / Elsevier
+- **ISSN:** 1470-2045 / 1474-5488
+- **Homepage:** https://www.thelancet.com/journals/lanonc
+- **Author guidelines:** https://www.thelancet.com/lanonc/information-for-authors
+
+## Scope
+Lancet Oncology publishes original research, reviews, and policy-focused content in clinical and translational oncology. It prioritizes large-scale international clinical trials, practice-changing therapeutic advances, cancer prevention and screening, and global oncology health policy. As part of the Lancet family, it values broad clinical impact, global health perspectives, and evidence that shapes cancer care delivery worldwide.
+
+## Scope Keywords
+clinical oncology, cancer, clinical trial, immunotherapy, targeted therapy, radiation oncology, surgical oncology, cancer prevention, screening, global oncology, health policy, precision medicine, cancer genomics, biomarkers, cancer epidemiology, survivorship, international multicenter, translational oncology
+
+## Article Types Accepted
+- Article (Original Research)
+- Review
+- Series
+- Viewpoint
+- Comment
+- Correspondence
+- Personal View
+- Commission
+
+## Classification
+- **Tier:** Q1
+- **Impact Factor:** ~36
+- **Open Access:** Hybrid (optional OA)
+- **Field:** Oncology
+
+## Special Notes
+Lancet Oncology is part of the Lancet Group and shares its editorial philosophy of broad clinical and policy impact. Transfer system within Lancet family (The Lancet, Lancet Digital Health, eClinicalMedicine). Lancet-style unstructured summary followed by structured research-in-context panel. The journal values international multicenter studies and global oncology perspectives. AI studies may be redirected to Lancet Digital Health unless demonstrating direct oncology clinical impact.
+
+## AI Writing Disclosure Policy
+- **Requirement level:** Required
+- **Permitted scope:** Language editing only — Acknowledgments disclosure required (Lancet Group policy)
+- **Disclosure location:** Acknowledgments section
+- **AI-generated images:** Must be disclosed; fabrication/falsification policies apply
+- **Policy URL:** https://www.thelancet.com/lanonc/information-for-authors

package/skills/find-journal/references/journal_profiles/Lancet_Psychiatry.md

@@ -0,0 +1,38 @@
+# The Lancet Psychiatry
+
+## Identity
+- **Abbreviation:** Lancet Psychiatry
+- **Publisher:** Lancet Group / Elsevier
+- **ISSN:** 2215-0366 / 2215-0374
+- **Homepage:** https://www.thelancet.com/journals/lanpsy
+- **Author guidelines:** https://www.thelancet.com/lanpsy/information-for-authors
+
+## Scope
+The Lancet Psychiatry publishes high-quality original research, reviews, and commentary in psychiatry and mental health. The journal emphasizes clinical research with global relevance, including large-scale clinical trials, epidemiologic studies, health services research, and policy-relevant investigations. It covers the full range of psychiatric conditions and prioritizes work that advances understanding, prevention, and treatment of mental illness worldwide.
+
+## Scope Keywords
+psychiatry, mental health, depression, psychosis, schizophrenia, bipolar disorder, anxiety, suicide prevention, substance use, global mental health, psychopharmacology, psychotherapy, clinical trial, epidemiology, health policy, child and adolescent psychiatry, forensic psychiatry, neuropsychiatry, digital psychiatry
+
+## Article Types Accepted
+- Article (Original Research)
+- Review
+- Series
+- Comment
+- Correspondence
+- Personal View
+- Health Policy
+
+## Classification
+- **Tier:** Q1
+- **Open Access:** Hybrid (optional OA)
+- **Field:** Psychiatry
+
+## Special Notes
+The Lancet Psychiatry is part of the Lancet family of journals. It has a strong global health and health policy orientation, emphasizing studies from low- and middle-income countries alongside high-income settings. The journal favors large RCTs, individual participant data meta-analyses, and studies with direct policy implications. Submissions follow Lancet Group conventions (structured Summary, no structured Introduction/Discussion).
+
+## AI Writing Disclosure Policy
+- **Requirement level:** Required
+- **Permitted scope:** Language editing only
+- **Disclosure location:** Acknowledgments
+- **AI-generated images:** Disclosure required if used
+- **Policy URL:** https://www.thelancet.com/lanpsy/information-for-authors

package/skills/find-journal/references/journal_profiles/Lancet_Public_Health.md

@@ -0,0 +1,30 @@
+# The Lancet Public Health
+
+## Identity
+- **Abbreviation:** Lancet Public Health
+- **Publisher:** Elsevier (The Lancet Group)
+- **ISSN:** 2468-2667
+- **Homepage:** https://www.thelancet.com/journals/lanpub/home
+- **Author guidelines:** https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(24)00248-3/fulltext
+
+## Scope
+The Lancet Public Health publishes original research, reviews, and commentary addressing population health, health equity, and public health policy worldwide. It prioritizes studies with implications for health systems, disease prevention, social determinants of health, and population-level interventions, with particular emphasis on global and underserved populations.
+
+## Scope Keywords
+public health, population health, health equity, epidemiology, health policy, social determinants, prevention, disease burden, global health, health systems, screening, vaccination, environmental health, non-communicable disease, health disparities
+
+## Article Types Accepted
+- Article (original research)
+- Review
+- Series
+- Comment
+- Correspondence
+- Viewpoint
+
+## Classification
+- **Tier:** Q1
+- **Open Access:** Full OA (no APC — Lancet Group covers costs)
+- **Field:** Public health / General medicine
+
+## Special Notes
+The Lancet Public Health is fully open access with no author charges, making it unique among high-impact public health journals. It follows Lancet Group formatting (unstructured summary, ~150 words; panels for key messages). Highly selective (~8% acceptance). Strong emphasis on health equity and LMIC research. Requires data sharing statement and EQUATOR checklist. AI policy: language editing only, Acknowledgments disclosure required, AI images banned (Lancet Group policy).

package/skills/find-journal/references/journal_profiles/Lancet_Respiratory_Medicine.md

@@ -0,0 +1,39 @@
+# Lancet Respiratory Medicine
+
+## Identity
+- **Abbreviation:** Lancet Respir Med
+- **Publisher:** Lancet / Elsevier
+- **ISSN:** 2213-2600 / 2213-2619
+- **Homepage:** https://www.thelancet.com/journals/lanres/home
+- **Author guidelines:** https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(13)X0014-4/fulltext
+
+## Scope
+The Lancet Respiratory Medicine publishes original research, reviews, and commentary on all aspects of respiratory medicine including asthma, COPD, interstitial lung disease, pulmonary infections (including COVID-19 and tuberculosis), lung cancer, pulmonary vascular disease, cystic fibrosis, sleep-disordered breathing, and critical care. The journal prioritizes large-scale clinical trials, epidemiological studies, and translational research with direct implications for patient care and public health.
+
+## Scope Keywords
+respiratory medicine, COPD, asthma, lung cancer, interstitial lung disease, pulmonary fibrosis, pneumonia, tuberculosis, COVID-19, pulmonary hypertension, critical care, mechanical ventilation, sleep medicine, cystic fibrosis, pulmonology
+
+## Article Types Accepted
+- Original Research (Articles)
+- Review
+- Series
+- Seminar
+- Personal View
+- Comment
+- Correspondence
+
+## Classification
+- **Tier:** Q1
+- **Impact Factor:** ~33
+- **Open Access:** Hybrid
+- **Field:** Pulmonology
+
+## Special Notes
+The Lancet Respiratory Medicine is the highest-impact specialty respiratory journal. It shares the Lancet Group editorial policies and submission platform. Manuscripts require a structured Summary (Background, Methods, Findings, Interpretation, Funding). The journal is highly selective and favors practice-changing RCTs, landmark observational studies, and high-quality meta-analyses. Lung imaging AI and CT screening studies are relevant if they demonstrate clinical outcome benefit.
+
+## AI Writing Disclosure Policy
+- **Requirement level:** Required
+- **Permitted scope:** AI tools may assist with writing but cannot be authors; authors retain full responsibility
+- **Disclosure location:** Acknowledgments or Methods section
+- **AI-generated images:** Must be disclosed
+- **Policy URL:** https://www.thelancet.com/pb/assets/raw/Lancet/authors/lancet-information-for-authors.pdf

package/skills/find-journal/references/journal_profiles/Liver_International.md

@@ -0,0 +1,33 @@
+# Liver International
+
+## Identity
+- **Abbreviation:** Liver Int
+- **Publisher:** John Wiley & Sons
+- **ISSN:** 1478-3223 / 1478-3231
+- **Homepage:** https://onlinelibrary.wiley.com/journal/14783231
+- **Author guidelines:** https://onlinelibrary.wiley.com/page/journal/14783231/homepage/forauthors.html
+- **Verification:** 2026-05-21 (against Wiley AGL PDF)
+
+## Scope
+Liver International promotes all aspects of the science of hepatology from basic research to applied clinical studies, publishing high-quality original research with clear clinical or translational significance. International multi-disciplinary forum for clinicians and basic scientists working on normal and abnormal structure and function of the liver.
+
+## Scope Keywords
+hepatology, liver disease, MASLD, NAFLD, MetALD, ALD, chronic hepatitis B, chronic hepatitis C, HCC, cirrhosis, liver fibrosis, FIB-4, liver transplantation, translational hepatology, liver biomarkers, cholangiopathy, acute liver failure, portal hypertension, clinical hepatology, basic hepatology
+
+## Article Types Accepted
+- Original Article
+- Systematic Review / Meta-Analysis
+- Brief Definitive Report
+- Review Article (invited; unsolicited considered)
+- Research Letter (within 6 months of cited paper; 1 per issue)
+- Editorial (invited)
+- Letter to the Editor (no case reports accepted)
+- Liver International Images
+
+## Classification
+- **Tier:** Q1 hepatology
+- **Open Access:** Hybrid (standard copyright OR CC license with APC)
+- **Field:** hepatology, clinical and translational liver research
+
+## Special Notes
+Explicit policy rejecting purely descriptive research, methodology-only papers, and case reports. Clinical trial registration mandatory (prospective registration; retrospective rejected). PRISMA checklist required for systematic reviews (auto-rejection otherwise). Continuous Publication model — no issue pagination. Lay Summary mandatory on revised Original Articles. AI policy: follows Wiley/ICMJE — disclose AI use in Methods or Acknowledgements; AI cannot be author; AI-generated image policy follows Wiley publisher-wide guidance (verify at journal homepage for any journal-specific amendments).

package/skills/find-journal/references/journal_profiles/Medical_Image_Analysis.md

@@ -0,0 +1,28 @@
+# Medical Image Analysis
+
+## Identity
+- **Abbreviation:** Med Image Anal, MedIA
+- **Publisher:** Elsevier
+- **ISSN:** 1361-8415 / 1361-8423
+- **Homepage:** https://www.sciencedirect.com/journal/medical-image-analysis
+- **Author guidelines:** https://www.elsevier.com/journals/medical-image-analysis/1361-8415/guide-for-authors
+
+## Scope
+Medical Image Analysis publishes original research on computational methods for medical image analysis, including segmentation, registration, detection, classification, and reconstruction. The journal bridges computer science and medical imaging, emphasizing novel algorithms validated on medical image data across all modalities (CT, MRI, X-ray, pathology, microscopy, ultrasound).
+
+## Scope Keywords
+medical image analysis, image segmentation, image registration, object detection, deep learning, convolutional neural networks, medical image classification, computer-aided diagnosis, pathology image analysis, 3D reconstruction, image-guided intervention, multi-modal fusion, semi-supervised learning, data augmentation, benchmark datasets
+
+## Article Types Accepted
+- Original Article
+- Short Communication
+- Review Article
+- Position Paper
+
+## Classification
+- **Tier:** Q1
+- **Open Access:** Hybrid
+- **Field:** Medical AI / Medical image computing
+
+## Special Notes
+Medical Image Analysis is the premier journal for computational medical image analysis research. It expects rigorous technical methodology with quantitative evaluation on medical datasets. Papers typically require comparison against state-of-the-art methods, ablation studies, and evaluation on multiple datasets. Clinical validation is valued but not required if the technical contribution is substantial. The journal has high standards for reproducibility.

package/skills/find-journal/references/journal_profiles/NEJM.md

@@ -0,0 +1,33 @@
+# The New England Journal of Medicine
+
+## Identity
+- **Abbreviation:** NEJM, N Engl J Med
+- **Publisher:** Massachusetts Medical Society
+- **ISSN:** 0028-4793 / 1533-4406
+- **Homepage:** https://www.nejm.org/
+- **Author guidelines:** https://www.nejm.org/author-center/new-manuscripts
+
+## Scope
+The New England Journal of Medicine publishes original research, reviews, and editorial opinion on all aspects of medicine, with emphasis on studies that have immediate relevance to clinical practice. It prioritizes large randomized controlled trials, landmark observational studies, and practice-changing discoveries across all medical specialties.
+
+## Scope Keywords
+clinical trials, randomized controlled trial, evidence-based medicine, internal medicine, surgery, oncology, cardiology, infectious disease, public health, therapeutics, drug efficacy, clinical outcomes, mortality, morbidity, practice-changing
+
+## Article Types Accepted
+- Original Article
+- Special Article
+- Review Article
+- Clinical Practice
+- Case Records of the Massachusetts General Hospital
+- Clinical Problem-Solving
+- Images in Clinical Medicine
+- Correspondence
+- Editorials
+
+## Classification
+- **Tier:** Q1
+- **Open Access:** Hybrid (selected articles OA; most subscription)
+- **Field:** General medicine
+
+## Special Notes
+NEJM is the highest-impact general medical journal. Manuscripts must demonstrate clear clinical significance with large sample sizes and robust methodology. AI/radiology papers are occasionally published if they demonstrate practice-changing clinical impact validated in large trials. Extremely competitive with single-digit acceptance rate.

package/skills/find-journal/references/journal_profiles/Nature_Machine_Intelligence.md

@@ -0,0 +1,31 @@
+# Nature Machine Intelligence
+
+## Identity
+- **Abbreviation:** Nat Mach Intell
+- **Publisher:** Springer Nature
+- **ISSN:** 2522-5839
+- **Homepage:** https://www.nature.com/natmachintell/
+- **Author guidelines:** https://www.nature.com/natmachintell/submission-guidelines
+
+## Scope
+Nature Machine Intelligence publishes research on machine learning, artificial intelligence, and robotics, with emphasis on studies that demonstrate significant methodological advances or impactful applications. Medical AI papers are published when they introduce novel algorithms, architectures, or learning paradigms with broad applicability beyond a single clinical domain.
+
+## Scope Keywords
+machine learning, deep learning, artificial intelligence, neural networks, computer vision, natural language processing, reinforcement learning, generative models, foundation models, AI methodology, medical AI, self-supervised learning, transfer learning, explainable AI, robotics
+
+## Article Types Accepted
+- Article (original research)
+- Brief Communication
+- Review
+- Perspective
+- Comment
+- Correspondence
+- Analysis
+
+## Classification
+- **Tier:** Q1
+- **Open Access:** Hybrid (Springer Nature transformative agreements)
+- **Field:** Computer science / Artificial intelligence
+
+## Special Notes
+Nature Machine Intelligence is a top-tier venue for AI methodology. Medical AI papers published here typically introduce novel architectures or training paradigms that are evaluated on medical data but have broader AI significance. Pure clinical validation studies without methodological novelty are better suited to clinical or radiology journals. The journal has strong interest in foundation models, multimodal learning, and AI safety/ethics.

package/skills/find-journal/references/journal_profiles/Nature_Medicine.md

@@ -0,0 +1,39 @@
+# Nature Medicine
+
+## Identity
+- **Abbreviation:** Nat Med
+- **Publisher:** Springer Nature
+- **ISSN:** 1078-8956 / 1546-170X
+- **Homepage:** https://www.nature.com/nm/
+- **Author guidelines:** https://www.nature.com/nm/submission-guidelines
+
+## Scope
+Nature Medicine publishes research that bridges basic and clinical science, with emphasis on translational studies that advance understanding of disease mechanisms, improve diagnostics, or develop novel therapies. The journal favors studies with clear translational impact, including clinical trials, biomarker discovery, and technology-driven advances in medicine.
+
+## Scope Keywords
+translational medicine, clinical trials, biomarkers, precision medicine, oncology, immunology, genomics, drug development, disease mechanisms, therapeutic targets, diagnostics, medical AI, digital health, gene therapy, cell therapy
+
+## Article Types Accepted
+- Article (original research)
+- Brief Communication
+- Review
+- Perspective
+- Correspondence
+- Analysis
+- Resource
+- Technical Report
+
+## Classification
+- **Tier:** Q1
+- **Open Access:** Hybrid (Springer Nature transformative agreements may cover OA)
+- **Field:** General medicine / Translational science
+
+## Special Notes
+Nature Medicine is highly receptive to medical AI studies that demonstrate clinical validation at scale. It values multi-center studies, external validation, and studies that combine novel methodology with clinical endpoints. Acceptance requires work at the intersection of innovation and clinical relevance. Preprints are allowed and even encouraged.
+
+## AI Writing Disclosure Policy
+- **Requirement level:** Required
+- **Permitted scope:** Language editing only
+- **Disclosure location:** Methods
+- **AI-generated images:** Banned
+- **Policy URL:** https://www.nature.com/nature-portfolio/editorial-policies/ai

package/skills/find-journal/references/journal_profiles/Neuroradiology.md

@@ -0,0 +1,31 @@
+# Neuroradiology
+
+## Identity
+- **Abbreviation:** Neuroradiology
+- **Publisher:** Springer Nature (European Society of Neuroradiology)
+- **ISSN:** 0028-3940 / 1432-1920
+- **Homepage:** https://www.springer.com/journal/234
+- **Author guidelines:** https://www.springer.com/journal/234/submission-guidelines
+
+## Scope
+Neuroradiology publishes original research, reviews, and case reports on imaging of the brain, spine, head and neck, and peripheral nervous system. It covers all neuroimaging modalities (CT, MRI, angiography, ultrasound) and spans neuro-oncology, cerebrovascular disease, neurodegeneration, pediatric neuroradiology, and interventional neuroradiology.
+
+## Scope Keywords
+neuroradiology, brain imaging, spine imaging, head and neck imaging, neuroimaging, stroke imaging, brain tumor, multiple sclerosis, cerebrovascular, intracranial aneurysm, interventional neuroradiology, perfusion imaging, diffusion tensor imaging, pediatric neuroimaging, MRI brain
+
+## Article Types Accepted
+- Original Article
+- Review Article
+- Diagnostic Neuroradiology (case-based)
+- Interventional Neuroradiology
+- Technical Note
+- Letter to the Editor
+- Pictorial Review
+
+## Classification
+- **Tier:** Q2
+- **Open Access:** Hybrid (Springer transformative agreements)
+- **Field:** Radiology / Neuroradiology
+
+## Special Notes
+Neuroradiology is the official journal of the European Society of Neuroradiology (ESNR). It accepts both diagnostic and interventional neuroradiology studies. Case reports are published under the "Diagnostic Neuroradiology" category. AI applications in brain and spine imaging are welcomed. The journal has a relatively fast review process compared to general radiology journals.

package/skills/find-journal/references/journal_profiles/Nutrition_Metabolism_and_Cardiovascular_Diseases.md

@@ -0,0 +1,39 @@
+# Nutrition, Metabolism and Cardiovascular Diseases (NMCD)
+
+## Identity
+- **Abbreviation:** Nutr Metab Cardiovasc Dis
+- **Publisher:** Elsevier
+- **ISSN:** 0939-4753 (print) / 1590-3729 (online)
+- **Homepage:** https://www.sciencedirect.com/journal/nutrition-metabolism-and-cardiovascular-diseases
+- **Author guidelines:** https://www.sciencedirect.com/journal/nutrition-metabolism-and-cardiovascular-diseases/publish/guide-for-authors
+
+## Scope
+NMCD is an international forum focusing on the relationship between nutritional and metabolic alterations and cardiovascular disorders. The journal addresses diabetes, atherosclerosis, hypertension, and other nutrition-related diseases through original clinical and experimental research in preventive medicine and vascular biology.
+
+## Scope Keywords
+cardio-metabolic, nutrition, metabolism, diabetes, atherosclerosis, hypertension, dyslipidemia, metabolic syndrome, cardiovascular-kidney-metabolic, CKM staging, obesity, insulin resistance, preventive medicine, vascular biology, lifestyle intervention, observational cohort, Mediterranean diet
+
+## Article Types Accepted
+- Original Article
+- Systematic Review
+- Meta-analysis
+- Viewpoint / Short Review
+- Institutional Review
+- Short Communication
+- Letter to the Editor
+
+## Classification
+- **Tier:** Q1–Q2 (cardiovascular / nutrition crossover)
+- **Open Access:** Hybrid — APC USD 3,560 for gold open access; subscription model available
+- **Field:** Cardio-metabolic medicine — nutrition and vascular biology crossover
+
+## Special Notes
+Editor-in-Chief Giovanni Targher, MD (Verona, Italy). Original Articles capped at **4,000 words**, 6 figures/tables, 60 references, with a **structured 250-word abstract: Background and Aims / Methods and Results / Conclusion**. Systematic Reviews and Meta-analyses permit 6,000 words, 120 references, 8 figures/tables. References use **numbered format [1], [2] in order of citation; first 6 authors should be listed followed by 'et al.'**. AI policy: declaration required on submission, with a dedicated statement before the references reading "During the preparation of this work the author(s) used [NAME OF TOOL / SERVICE] in order to [REASON]"; AI cannot be listed as author; basic grammar/spell-check tools exempt. Submission portal: https://www.editorialmanager.com/nmcd. Choose NMCD when the manuscript foregrounds the nutrition–metabolism–CVD axis (e.g., Mediterranean diet, metabolic syndrome cluster, MASLD–CVD interactions) over a pure cardiology framing.
+
+
+---
+
+## Verification
+- **Source:** https://www.sciencedirect.com/journal/nutrition-metabolism-and-cardiovascular-diseases/publish/guide-for-authors
+- **Date (harvested from private profile):** 2026-05-20
+- **Date (promoted to public):** 2026-05-21

package/skills/find-journal/references/journal_profiles/PLOS_Medicine.md

@@ -0,0 +1,32 @@
+# PLOS Medicine
+
+## Identity
+- **Abbreviation:** PLoS Med
+- **Publisher:** Public Library of Science (PLOS)
+- **ISSN:** 1549-1277 / 1549-1676
+- **Homepage:** https://journals.plos.org/plosmedicine/
+- **Author guidelines:** https://journals.plos.org/plosmedicine/s/submission-guidelines
+
+## Scope
+PLOS Medicine publishes research and commentary of general interest to the international medical and public health communities. It favors studies with broad implications for clinical practice, health policy, or global health, particularly those addressing health equity, disease burden, and evidence synthesis.
+
+## Scope Keywords
+global health, public health, epidemiology, health policy, clinical trials, meta-analysis, systematic review, health equity, infectious disease, non-communicable disease, evidence synthesis, health systems, screening, prevention, population health
+
+## Article Types Accepted
+- Research Article
+- Meta-Research Article
+- Systematic Review and Meta-Analysis
+- Essay
+- Perspective
+- Editorial
+- Collection Review
+- Guidelines and Guidance
+
+## Classification
+- **Tier:** Q1
+- **Open Access:** Full OA
+- **Field:** General medicine / Public health
+
+## Special Notes
+PLOS Medicine is fully open access and charges an article processing charge. It is particularly strong in systematic reviews, meta-analyses, and global health studies. The journal requires a data availability statement and encourages preregistration. It has a dedicated interest in meta-research (research on research) and reporting guideline adherence.

package/skills/find-journal/references/journal_profiles/RYAI.md

@@ -0,0 +1,28 @@
+# Radiology: Artificial Intelligence
+
+## Identity
+- **Abbreviation:** Radiol Artif Intell
+- **Publisher:** Radiological Society of North America (RSNA)
+- **ISSN:** 2638-6100 / 2638-6100
+- **Homepage:** https://pubs.rsna.org/journal/ai
+- **Author guidelines:** https://pubs.rsna.org/page/ai/submission-guidelines
+
+## Scope
+Radiology: Artificial Intelligence publishes original research on AI and machine learning methodology, development, and validation in medical imaging, covering all stages from algorithm development through clinical deployment and fairness assessment.
+
+## Scope Keywords
+artificial intelligence, deep learning, machine learning, medical imaging AI, computer-aided detection, radiomics, natural language processing, large language models, convolutional neural networks, transformers, segmentation, classification, object detection, model validation, AI fairness, clinical deployment, explainability
+
+## Article Types Accepted
+- Original Research
+- Technical Note
+- Review Article
+- Letter to the Editor
+
+## Classification
+- **Tier:** Q1
+- **Open Access:** Hybrid
+- **Field:** Radiology / Artificial intelligence
+
+## Special Notes
+Radiology: Artificial Intelligence is the premier AI-focused radiology journal (IF ~8), a sister journal to Radiology. CLAIM checklist is mandatory for all AI studies. Strong emphasis on reproducibility, requiring code availability statements and model cards. Accepts AI studies at any development stage (unlike flagship Radiology which requires full clinical validation). AI policy: language editing only, dual disclosure required, AI images banned.

package/skills/find-journal/references/journal_profiles/Radiology.md

@@ -0,0 +1,29 @@
+# Radiology
+
+## Identity
+- **Abbreviation:** Radiology
+- **Publisher:** Radiological Society of North America (RSNA)
+- **ISSN:** 0033-8419 / 1527-1315
+- **Homepage:** https://pubs.rsna.org/journal/radiology
+- **Author guidelines:** https://pubs.rsna.org/page/radiology/submission-guidelines
+
+## Scope
+Radiology is the flagship journal of radiology, publishing practice-changing original research and reviews across all imaging modalities and subspecialties, with emphasis on large multi-center studies, prospective designs, and clinically validated AI applications.
+
+## Scope Keywords
+diagnostic radiology, interventional radiology, CT, MRI, ultrasound, PET, nuclear medicine, oncologic imaging, cardiovascular imaging, thoracic imaging, abdominal imaging, neuroradiology, musculoskeletal imaging, AI clinical validation, imaging biomarkers, multi-center trials, screening
+
+## Article Types Accepted
+- Original Research
+- Review Article
+- Technical Developments
+- Case Report
+- Letter to the Editor
+
+## Classification
+- **Tier:** Q1
+- **Open Access:** Hybrid (RSNA Open Access)
+- **Field:** Radiology (general, flagship)
+
+## Special Notes
+Radiology (IF ~19) is the highest-impact general radiology journal with approximately 5-8% acceptance rate. Requires a Summary Statement (single sentence, <=50 words) and 3 Advances in Knowledge bullets. Strictly enforces a 6-figure limit. Expects large sample sizes (N >= 200 typical, N >= 500 preferred for prospective studies). AI policy: language editing only, dual disclosure required, AI images banned.

package/skills/find-journal/references/journal_profiles/Skeletal_Radiology.md

@@ -0,0 +1,31 @@
+# Skeletal Radiology
+
+## Identity
+- **Abbreviation:** Skeletal Radiol
+- **Publisher:** Springer Nature (International Skeletal Society)
+- **ISSN:** 0364-2348 / 1432-2161
+- **Homepage:** https://www.springer.com/journal/256
+- **Author guidelines:** https://www.springer.com/journal/256/submission-guidelines
+
+## Scope
+Skeletal Radiology publishes original research, reviews, and case reports on imaging of the musculoskeletal system. Coverage includes bone and soft tissue tumors, arthritis, sports injuries, metabolic bone disease, congenital anomalies, and spinal disorders as they relate to musculoskeletal imaging across all modalities (radiography, CT, MRI, ultrasound).
+
+## Scope Keywords
+musculoskeletal imaging, bone tumor, soft tissue tumor, arthritis, sports injury, MRI musculoskeletal, bone marrow, cartilage imaging, fracture, osteoporosis, joint imaging, skeletal dysplasia, ultrasound musculoskeletal, spinal imaging, orthopedic radiology
+
+## Article Types Accepted
+- Scientific Article
+- Review Article
+- Case Report
+- Technical Report
+- Test Yourself (quiz case)
+- Letter to the Editor
+- Pictorial Essay
+
+## Classification
+- **Tier:** Q2
+- **Open Access:** Hybrid (Springer transformative agreements)
+- **Field:** Radiology / Musculoskeletal imaging
+
+## Special Notes
+Skeletal Radiology is the official journal of the International Skeletal Society and the Musculoskeletal Tumor Society (radiology section). It is one of the few radiology journals that actively publishes case reports. The journal has particular strength in musculoskeletal tumor imaging and sports medicine radiology. AI applications in MSK imaging are increasingly featured.

package/skills/find-journal/references/journal_profiles/Stroke.md

@@ -0,0 +1,37 @@
+# Stroke (AHA/ASA)
+
+## Identity
+- **Abbreviation:** Stroke
+- **Publisher:** American Heart Association / American Stroke Association (Wolters Kluwer / Lippincott)
+- **ISSN:** 0039-2499 (print) / 1524-4628 (online); ISSN-L 0039-2499
+- **Homepage:** https://www.ahajournals.org/journal/str
+- **Author guidelines:** https://www.ahajournals.org/stroke/author-instructions
+- **Submission email:** stroke@strokeahajournal.org
+- **Editor-in-Chief:** Argye E. Hillis
+
+## Scope
+Stroke is the AHA/ASA's flagship cerebrovascular journal, publishing basic, translational, clinical, and population science on ischemic stroke, intracerebral and subarachnoid hemorrhage, cerebral small vessel disease, cerebrovascular imaging, acute stroke treatment (IV thrombolysis, endovascular therapy), secondary prevention, and stroke systems of care. Articles are triaged into three science categories — Basic/Translational, Clinical, and Population — at submission.
+
+## Scope Keywords
+ischemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, transient ischemic attack, mechanical thrombectomy, IV thrombolysis, cerebral small vessel disease, stroke epidemiology, vascular cognitive impairment, stroke recovery, stroke systems of care, cerebrovascular imaging, carotid disease, intracranial atherosclerosis, basic cerebrovascular biology
+
+## Article Types Accepted
+- Original Research (Basic/Translational, Clinical, Population)
+- Brief Report
+- Research Letter
+- Review / Progress Review
+- Emerging Therapy Critique
+- Special Report
+- Comments and Opinions
+- Stroke Images (clinical or basic)
+- Illustrative Teaching Case
+- InterSECT (multi-author clinical reasoning)
+- Editorial / Letter to the Editor / Response
+
+## Classification
+- **Tier:** Q1
+- **Open Access:** Hybrid (subscription + optional Gold OA)
+- **Field:** Stroke / cerebrovascular disease (basic + clinical + population)
+
+## Special Notes
+The AHA/ASA flagship stroke journal. Approximately 50% rejection rate on initial review. Structured 300-word abstract for Original Research; Vancouver numbered references listing the first 10 authors followed by "et al." Original Research caps at 5000 words with up to 50 references and 8 figures/tables combined. Research Letters (750 words, 5 references, 1 figure/table, no abstract) are a fast-track format. Revision window 90 days; Graphic Abstract is required at revision stage. Acceptance of manuscript triggers entry to the AHA multi-journal portal ecosystem (ATVB, Circulation Research, Hypertension, S:VIN, JAHA) — cross-journal transfer is offered for rejected work that fits another AHA journal. AI policy is explicit: generative AI is permitted with documentation, cannot be an author (ICMJE), must be listed in Acknowledgments, documented in Methods if used in research design, exempt for grammar/spell-check only; AI image manipulation is prohibited. Choose Stroke over Journal of Stroke when target audience is global (North American + European) rather than Asia-Pacific, or when subscription/hybrid is acceptable; choose Journal of Stroke when no-APC OA is required.